Renato Skerlj

CEO, President & Board Member

Dr. Skerlj has more than 25 years of experience leading the discovery and development of disease modifying small molecule drugs to treat genetically defined rare diseases. He has authored 67 publications, holds 52 patents and has advanced multiple drug candidates into clinical development.

Most recently, Dr. Skerlj served as Chief Scientific Of...


Roles at Expansion Therapeutics

  • CEO, President & Board Member

    October 5, 2020 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Expansion Therapeutics

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.